about
Human chorionic gonadotrophin for threatened miscarriageHuman chorionic gonadotrophin for threatened miscarriageRecurrent miscarriage: pathophysiology and outcomeThrombophilia and pregnancy lossAntiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatmentHeparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failureSustained relief of leiomyoma symptoms by using focused ultrasound surgeryDeregulation of the serum- and glucocorticoid-inducible kinase SGK1 in the endometrium causes reproductive failureSafety and treatment volumes achieved following new developments of the magnetic resonance-guided focused ultrasound system in the treatment of uterine fibroids: a cohort studyClinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids.Interstitial thermo-ablation under MRI guidance for the treatment of fibroids.Magnetic resonance-guided percutaneous laser ablation of uterine fibroids.A new biological and clinical resource for research into pregnancy complications: The Baby Bio BankNatural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantationNatural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss.Waddlia chondrophila, a potential agent of human fetal death.Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.Vaginal birth after cesarean: the European experience.Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis.Natural killer cells, miscarriage, and infertility.Obstetric opinions regarding the method of delivery in women that have had surgery for retinal detachment.Measurement of uterine fibroid volume: a comparative accuracy and validation of methods study.Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing.Managing miscarriage.Influence of past reproductive performance on risk of spontaneous abortionMRI guidance of focused ultrasound therapy of uterine fibroids: early results.PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.Recurrent early pregnancy failure.Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)The effect of body mass index on the outcome of pregnancy in women with recurrent miscarriageGlucose production in the human placenta.Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.Placental pathology of recurrent spontaneous abortion: the role of histopathological examination of products of conception in routine clinical practice: a mini review.Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes.Paternally expressed, imprinted insulin-like growth factor-2 in chorionic villi correlates significantly with birth weight.A further look at infection at the time of therapeutic abortion.The importance of preconception counseling and early pregnancy monitoring.Unexplained recurrent pregnancy loss.Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome.Heparin prevents programmed cell death in human trophoblast.
P50
Q24235430-3E0171AD-A588-4E68-81F5-332B7F706852Q24242026-19EBE009-3298-4EEC-9406-572E8C915131Q28192977-C5159DA4-7238-497D-A956-D3E74A0ABFBAQ28193189-4E30952A-F581-4630-AD90-7A4C3FDBE4EAQ28194379-E3ACA663-CE5B-4B09-8760-E580A0B4AC19Q28213788-B80DB3D1-5A53-4091-B6CB-58398769526DQ28238735-D496A481-065F-41F7-898F-F2B4E4D1B144Q28250572-4F1D7A0A-96F4-4DF8-8C0B-5ED46863FB20Q30422871-6BC5F51F-AC85-4975-92E0-B7A207980837Q30857372-B5BEAD0C-2BBF-4066-B748-4A02E001BBECQ30909392-F0A42EA5-04A0-42CE-85BA-A2035A71C828Q30948161-5529F4D3-9E09-4057-8CFC-A523A31C2A8EQ33458633-D9CCE915-29BC-46B4-A958-735073A2209DQ33565584-A4C6A474-8CF2-4A95-90C2-63F705EF5EB6Q33565602-38212B37-70D2-404E-A94B-E5702EC6DAF0Q33686265-462D9BE7-6061-4955-A3AB-42B16AA4CD37Q34245469-70E1EB43-94B6-4F80-9250-0693C20DA584Q34422872-FC2D80ED-9C1E-4E52-8016-F5CB1AD8E86FQ34452378-BCC4F780-EAF0-4F4E-83EA-78932EF20B89Q34552848-205A1B15-73E9-4314-AD6A-3A3461329417Q34904490-B185FE9E-B126-46F9-9612-08BF33C6E128Q34987126-458A9682-CF07-471E-AD86-75F29A165DA3Q35360929-23B81711-582A-44AF-9E9A-1A15FD65150FQ35555700-9B4039DF-DD2F-4D5F-AB6A-FD955F1746D6Q35715568-F76AFABE-6C46-4157-9694-1E9FC047D50BQ35952278-63496E6D-7824-4B74-875B-E5ED2C77D68FQ36029503-1B3BD521-8D97-42C5-BD7C-C2D1D6405CB6Q36044031-70DDFA1E-3AE5-470A-8FC4-D04968E7287FQ36242479-0D94FC85-1DED-4367-BE14-88E01E7CDF30Q36449742-7F3FE3EC-64F5-49F4-AD91-02B428A3BA3CQ36450819-DEF40DE2-2B02-42BB-90A5-E679F1136B6DQ36598852-EB7910B4-9A0D-4A10-ADD1-DD21A5039E16Q36606642-12A41747-FC82-4B5D-8BB2-BF3B991DEFD7Q37056121-2FF8C9FF-88D2-4D62-B85D-C71033B66863Q37484070-76F1F296-D4AD-4B58-BD16-2D5736E51B62Q37895828-E6F3D5D7-DD38-4474-A04F-EBA5F3182E10Q37967541-148171BE-8E71-4628-A17F-4CD98822BBC2Q38184781-2D7DE25B-FEFB-4DA4-86C0-4B2E559369F9Q38440245-4CE1C732-FDE0-4C38-AA83-417F7ADCFFA4Q40300623-CBAF51A8-E4F6-444C-880A-F8E937656FEF
P50
description
British gynaecologist
@en
British gynaecologist
@en-ca
British gynaecologist
@en-gb
ginecóloga británica
@es
gynaecoloog
@nl
أخصائية أمراض نسائية بريطانية
@ar
name
Lesley Regan
@ast
Lesley Regan
@de
Lesley Regan
@en
Lesley Regan
@es
Lesley Regan
@it
Lesley Regan
@nl
Lesley Regan
@sl
type
label
Lesley Regan
@ast
Lesley Regan
@de
Lesley Regan
@en
Lesley Regan
@es
Lesley Regan
@it
Lesley Regan
@nl
Lesley Regan
@sl
prefLabel
Lesley Regan
@ast
Lesley Regan
@de
Lesley Regan
@en
Lesley Regan
@es
Lesley Regan
@it
Lesley Regan
@nl
Lesley Regan
@sl
P1015
P227
P1015
P1207
n2016086501
P21
P213
0000 0004 1855 2495
P214
8374147967375784200003
P227
P31
P569
1956-03-08T00:00:00Z
1957-01-01T00:00:00Z
P735
P7859
viaf-8374147967375784200003